Amrutanjan Health Care reports strong FY25 growth, sets AGM date

Amrutanjan Health Care Limited reported significant growth for the financial year 2024-25, with gross sales reaching ₹509.68 Cr, up from ₹471.82 Cr in the previous year. Profit After Tax (PAT) increased to ₹50.83 Cr from ₹44.97 Cr, and Net Worth rose to ₹326.61 Cr from ₹288.49 Cr. Earnings Per Share (EPS) for FY25 stood at ₹17.58, compared to ₹15.50 in FY24, while the dividend per share remained constant at ₹4.60. The company’s market cap reached ₹1,864 Cr, up from ₹1,789 Cr in FY24.

The company's pain management category saw a 6% overall growth, driven by small SKUs and Head Roll-On. Women’s hygiene (Comfy) was the fastest-growing segment with an 18% overall growth, and the rehydration segment (Electro+) grew by 10%. Amrutanjan also focused on digital transformation, with 60% of critical processes now digitized through SAP and allied platforms, and expanded its international footprint across 13 countries and 4 continents. The 88th Annual General Meeting will be held on September 23, 2025, to approve these results and discuss future strategies.